Researchers at BYU have devised a system to speed up the process of making life-saving vaccines for new viruses.
Their concept is to create the biological machinery for vaccine production en masse, put it in a freeze-dried state and stockpile it around the country. Then, when a new virus hits, labs can simply add water to a “kit” to rapidly produce vaccines.
“You could just pull it off the shelf and make it,” said senior author Brad Bundy, associate professor of chemical engineering. “We could make the vaccine and be ready for distribution in a day.”
The research, published in Biotechnology Journal, demonstrates the ability to store the drug and vaccine-making machinery for more than a year.
Traditional systems to produce vaccines for pandemic influenza strains require heavy engineering and specialized equipment that only a few labs across the country have on hand. These traditional systems are also time-consuming, taking months to execute.
Bundy’s idea is a new angle on the emerging method of “cell-free protein synthesis,” a process that combines DNA to make proteins needed for drugs (instead of growing protein in a cell). His lab is creating a system where the majority of the work is done beforehand so vaccine kits can be ready to go and be activated at the drop of a dime.
“It will not only provide a quicker response to pandemics, but it will also make protein-based drugs more available to third-world countries where production and refrigerated storage can be problematic,” added William Pitt, a study coauthor and fellow BYU professor of chemical engineering.
While the team is now testing their version of the cell-free, recombinant DNA process for vaccine production, they’ve already successfully demonstrated it for at least one anti-cancer protein (onconase).
The researchers believe their method can significantly reduce investment of time and money towards future drug production and, in turn, reduce treatment expenses for patients.
“The drugs today are changing,” Bundy said. “The lifesaving cancer drugs we have now, the drugs for arthritis, the drugs with the greatest impact, are made out of proteins, not small chemical molecules. This method takes full advantage of that to provide a quicker, more personal response.”
The Latest on: Making vaccines
via Google News
The Latest on: Making vaccines
- How Long Will It Take to Develop a Vaccine for the Wuhan Virus?on January 27, 2020 at 2:54 pm
“And that’s because neither of these vaccines tend to make money.” Hotez and his team have been working for years on a vaccine against a virus closely related to 2019-nCoV: the virus that causes SARS.
- Johnson & Johnson is 'pretty confident' it can make a coronavirus vaccine that gives 'long-term' protection - but it may take a year to developon January 27, 2020 at 1:04 pm
The company is tarting from scratch. 'We are going to take an approach with at least five different constructs and different partners and collaborations all over the world in order to see which part ...
- Inovio Pharma Awarded $9M Development Grant for Coronavirus Vaccineon January 27, 2020 at 11:56 am
We have already demonstrated positive clinical outcomes with our vaccine against MERS-CoV, another coronavirus ... Directors, officers, employees or members of their immediate families are prohibited ...
- Sending out coronavirus vaccines won't make sense unless the spread gets worseon January 27, 2020 at 10:28 am
Yes, even vaccines have a danger, however much the anti-vaccine crowd is deranged on the ... or possibly healthcare for other problems if the CDC gets to decide. The first option will make those ...
- J&J scientific officer 'pretty confident' they can create coronavirus vaccine as outbreak widenson January 27, 2020 at 10:03 am
Johnson & Johnson's chief scientific officer said he believes the drugmaker can create a vaccine in the coming months to fight against the fast-spreading coronavirus. But Dr. Paul Stoffels said it ...
- 3 Biotech Stocks Are Soaring Because Everyone Wants a Coronavirus Vaccineon January 27, 2020 at 9:50 am
Yet despite enthusiasm from investors, analysts caution that it’s unlikely the vaccines under development could make it to market in time to see revenue from the current outbreak. “Companies stating ...
- J&J launches vaccine efforts as coronavirus spreadson January 27, 2020 at 9:20 am
"We are going to take a parallel approach with at least five different constructs, with different partners, collaborators over the world in order to see which part of the virus we can use to make an ...
- Scientists are moving at record speed to create new coronavirus vaccines—but they may come too lateon January 27, 2020 at 4:35 am
Of course, the 2019-novel coronavirus (2019-nCoV), as it is now dubbed, has a solid lead in the race, and by the time a vaccine proves its worth in a clinical trial and manufacturers scale up ...
- With coronavirus genetic code in hand, scientists begin work on a vaccineon January 27, 2020 at 3:48 am
Fauci’s agency is partnering with U.S. biotech Moderna Inc., which specializes in vaccines based on ribonucleic acid (RNA) — a chemical messenger that contains instructions for making proteins. That ...
- RPT-With Wuhan virus genetic code in hand, scientists begin work on a vaccineon January 27, 2020 at 3:14 am
When a newly organised vaccine research group at the U.S. National Institutes of Health (NIH) met for the first time this week, its members had expected to be able to ease into their work. But their ...
via Bing News